REQUEST A DEMO
Total
USD $0.00
Search more companies

Dr.Max 192 S.R.O. (Slovakia)

Main Activities: Pharmacies and Drug Stores | Department Stores
Full name: Dr.Max 192 S.R.O. Profile Updated: October 21, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Dr.Max 192 S.R.O. is based in Slovakia. The head office is in Kosice. The enterprise currently operates in the Pharmacies and Drug Stores sector. It was first established on March 26, 2020. The company’s latest financial report indicates a net sales revenue increase of 108470000% in 2024. Over the same period, its total assets grew by 61.4%.

Headquarters
Moldavska cesta, 8/A
Kosice; Kosicky; Postal Code: 04011

Contact Details: Purchase the Dr.Max 192 S.R.O. report to view the information.

Basic Information
Registered Capital:
Purchase the Dr.Max 192 S.R.O. report to view the information.
Financial Auditors:
Purchase the Dr.Max 192 S.R.O. report to view the information.
Incorporation Date:
March 26, 2020
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Dr.Max 192 S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
108470000%
Total operating revenue
108592800%
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
N/A
Total assets
61.4%
Total equity
227.84%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
-0.57%
Quick Ratio
0.27%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?